Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Sepracor-Looks very promising -- Ignore unavailable to you. Want to Upgrade?

To: Bob Swift who wrote (2033)	3/18/1999 8:18:00 PM
From: dennis michael patterson	Read Replies (1) \| Respond to of 10280

From Barrons today: interactive.wsj.com

To: Bob Swift who wrote (2033)	3/18/1999 8:37:00 PM
From: M. Ramle	Read Replies (1) \| Respond to of 10280

Bob: I don't know about you, but there is absolutely no question in mind that yesterday's and today's trading was purposely manipulated for Option-Expiration, and just look at today's closing price of $125, which means that all the hefty-premium March Call Options with Strike Prices greater than $125 have pretty much lost their entire value (largest open interest was centered around strike prices of $125 & $130). Having said that, my prediction for tomorrow is that we might open slightly lower around the $123-124 area which I would like to see hold, and given the recent drop from $140 7/8 down to today's low of $122 1/2, there is still NO technical violation and/or damage on the chart as of yet. I don't know about you, but I personally have been buying on this downturn, and would still buy some more tomorrow at the opening dip (if it ever occurs) for the next leg-up which should take us to the $150-152 level. In the meantime, keep an eye on today's intraday low of $122 1/2 which should NOT be violated, otherwise, I would look for a sharp drop towards the $105 area. IMHO, the best thing that could happen to SEPR right now is for some positive news about FDA's approval for Levalbuterol, Stock split, SGP filing NDA for Claritin "D", settlement of patent dispute re. Alegra, FTC clearing the LLY/SEPR venture for "Super" Prozac and/or a major joint-venture announcement just when the DJIA is about to cross the 10K. Any of these events would most certainly propel us to new highs. GOOD LUCK. Mazen PS: One of these days, I promise you I am going to give the same message back to these crooked MM's.